Claudin 17 Antikörper (AA 103-152)
-
- Target Alle Claudin 17 (CLDN17) Antikörper anzeigen
- Claudin 17 (CLDN17)
-
Bindungsspezifität
- AA 103-152
-
Reaktivität
- Human, Maus, Ratte, Hund, Rind (Kuh), Schwein, Pferd, Schaf, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Claudin 17 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Human CLDN17 / Claudin 17
- Homologie
- Percent identity by BLAST analysis: Rat, Dog, Pig (100%) Sheep, Bovine (84%).
- Aufreinigung
- Protein A purified
- Immunogen
-
Synthetic peptide located between aa103-152 of human CLDN17 (P56750, NP_036263). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Mouse, Rat, Dog, Horse, Pig (100%), Rabbit, Guinea pig (91%), Sheep, Bovine (84%).
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
-
-
- Applikationshinweise
- Approved: IHC, IHC-P, WB (2 μg/mL)
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- Claudin 17 (CLDN17)
- Andere Bezeichnung
- CLDN17 / Claudin 17 (CLDN17 Produkte)
- Synonyme
- CLDN17 antikoerper, Claudin-17 antikoerper, zgc:173444 antikoerper, claudin 17 antikoerper, CLDN17 antikoerper, cldn17 antikoerper, Cldn17 antikoerper
- Hintergrund
-
Name/Gene ID: CLDN17
Family: Claudin
Synonyms: CLDN17, Claudin 17, Claudin-17 - Gen-ID
- 26285
- NCBI Accession
- NP_036263
- UniProt
- P56750
- Pathways
- Cell-Cell Junction Organization, Hepatitis C
-